Biotia
Biotia is a health-tech company based in New York, NY, dedicated to fighting infectious diseases through sequencing technology and AI-powered software. They develop advanced diagnostics and pathogen surveillance tools, including platforms like GeoSeeq and BIOTIA-DX, to improve infectious disease detection, research, and public health response. Their mission is to create the world's leading microbial sequence database and provide rapid, accurate diagnostics to enhance patient outcomes and reduce healthcare costs.
Industries
Nr. of Employees
small (1-50)
Products
Clinical-grade urine NGS diagnostic assay (state-authorized LDT)
An NGS-based in vitro diagnostic urine assay that detects a curated panel of urogenital pathogens and antimicrobial resistance markers; validated in a CLIA laboratory and approved as a state LDT.
Clinical-grade pathogen analysis software (research and clinical license)
A licensed bioinformatics application that analyzes metagenomic and targeted sequencing data to identify pathogens, call variants, and detect resistance genes, and produces interactive visualizations and reports for research or clinical use.
Research influenza genomics analysis workflow
Bioinformatic tool to analyze avian influenza virus genomes from NGS data including segment typing, clade/subclade assignment, cleavage site and mutation identification for surveillance research.
Multiplex PCR panel testing (respiratory and GI)
Provision of FDA-authorized multiplex PCR panels for respiratory and gastrointestinal pathogen detection performed in the clinical laboratory using established commercial instruments.
Clinical-grade urine NGS diagnostic assay (state-authorized LDT)
An NGS-based in vitro diagnostic urine assay that detects a curated panel of urogenital pathogens and antimicrobial resistance markers; validated in a CLIA laboratory and approved as a state LDT.
Clinical-grade pathogen analysis software (research and clinical license)
A licensed bioinformatics application that analyzes metagenomic and targeted sequencing data to identify pathogens, call variants, and detect resistance genes, and produces interactive visualizations and reports for research or clinical use.
Research influenza genomics analysis workflow
Bioinformatic tool to analyze avian influenza virus genomes from NGS data including segment typing, clade/subclade assignment, cleavage site and mutation identification for surveillance research.
Multiplex PCR panel testing (respiratory and GI)
Provision of FDA-authorized multiplex PCR panels for respiratory and gastrointestinal pathogen detection performed in the clinical laboratory using established commercial instruments.
Services
Global pathogen biosurveillance platform
Cloud platform that integrates microbial sequencing data, epidemiological metadata and environmental/satellite data with AI tools and dashboards to support collaboration, surveillance and early-warning activities.
Clinical-grade pathogen genomic analysis (bioinformatics) as a service
Analysis pipelines that convert raw sequencing data into reports with species identification, assembled genomes, lineage assignments, AMR gene detection, and visualizations; available for research and clinical workflows.
Local biosurveillance hub deployment and training
Operational support to establish local sequencing- and surveillance-capable 'watchtower' sites in underserved regions, including equipment, workflows and training to generate local genomic data streams.
Clinical laboratory testing services (NGS-based assays)
Provision of NGS-based clinical testing for detection of urogenital and other infection-causing pathogens from clinical specimens in a CLIA/CLEP-certified laboratory, including report delivery to clinicians and patient portals.
Research-use sequencing assays and analytical reports
RUO NGS assays and specialized analyses for research applications (e.g., joint fluid sequencing, influenza analysis, SARS-CoV-2 variant profiling), delivered with publication-grade outputs.
Global pathogen biosurveillance platform
Cloud platform that integrates microbial sequencing data, epidemiological metadata and environmental/satellite data with AI tools and dashboards to support collaboration, surveillance and early-warning activities.
Clinical-grade pathogen genomic analysis (bioinformatics) as a service
Analysis pipelines that convert raw sequencing data into reports with species identification, assembled genomes, lineage assignments, AMR gene detection, and visualizations; available for research and clinical workflows.
Local biosurveillance hub deployment and training
Operational support to establish local sequencing- and surveillance-capable 'watchtower' sites in underserved regions, including equipment, workflows and training to generate local genomic data streams.
Clinical laboratory testing services (NGS-based assays)
Provision of NGS-based clinical testing for detection of urogenital and other infection-causing pathogens from clinical specimens in a CLIA/CLEP-certified laboratory, including report delivery to clinicians and patient portals.
Research-use sequencing assays and analytical reports
RUO NGS assays and specialized analyses for research applications (e.g., joint fluid sequencing, influenza analysis, SARS-CoV-2 variant profiling), delivered with publication-grade outputs.
Expertise Areas
- Clinical metagenomic diagnostics
- Pathogen genomics and biosurveillance
- Bioinformatics and AI for antimicrobial resistance
- NGS assay development and validation
Key Technologies
- Next-generation sequencing (short-read)
- Long-read sequencing (ONT)
- Hybrid-capture sequencing
- Amplicon-based sequencing